Exosomal circular RNAs: A chief culprit in cancer chemotherapy resistance

被引:87
作者
Guo, Xu [1 ]
Gao, Congying [2 ]
Yang, Dong-Hua [3 ]
Li, Shenglong [4 ]
机构
[1] China Med Univ, Dalian Univ Technol, Liaoning Canc Hosp & Inst, Dept Neurosurg,Canc Hosp, Shenyang 110042, Liaoning, Peoples R China
[2] Weifang Med Univ, Sch Pharm, Weifang, Peoples R China
[3] New York Coll Tradit Chinese Med, Mineola, NY 11501 USA
[4] China Med Univ, Dalian Univ Technol, Liaoning Canc Hosp & Inst, Canc Hosp,Dept Bone & Soft Tissue Tumor Surg, Shenyang 110042, Liaoning, Peoples R China
关键词
Exosome; Circular RNA (circRNA); Chemotherapy resistance; Cancer; CELL LUNG-CANCER; HEPATOCELLULAR-CARCINOMA; TUMOR MICROENVIRONMENT; NASOPHARYNGEAL CARCINOMA; CISPLATIN RESISTANCE; DOCETAXEL RESISTANCE; PANCREATIC-CANCER; PROSTATE-CANCER; PROMOTES; PROGRESSION;
D O I
10.1016/j.drup.2023.100937
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Chemotherapy is one of the primary treatments for malignant tumors. However, the acquired drug resistance hinders clinical efficacy and leads to treatment failure in most patients. Exosomes are cell-derived vesicles with a diameter of 30-150 nm carrying and delivering substances such as DNAs, RNAs, lipids, and proteins for cellular communication in tumor development. Circular RNAs (circRNAs) present covalently closed-loop RNA structures, which regulate tumor cell proliferation, apoptosis, and metastasis by controlling different genes and signaling pathways. CircRNAs are abundant and stably expressed in exosomes. Recent studies have shown that they play critical roles in chemotherapy resistance in various cancers. In this review, we summarized the origin of exosomes and discussed the regulation mechanism of exosomal circRNAs in cancer drug resistance.
引用
收藏
页数:16
相关论文
共 191 条
  • [1] A N.V.L.K., 2021, BIOMATER ADV
  • [2] Exosomes loaded with circPARD3 promotes EBV-miR-BART4-induced stemness and cisplatin resistance in nasopharyngeal carcinoma side population cells through the miR-579-3p/SIRT1/SSRP1 axis
    Ai, Jingang
    Tan, Guolin
    Li, Wei
    Liu, Honghui
    Li, Tieqi
    Zhang, Gehou
    Zhou, Zheng
    Gan, Yu
    [J]. CELL BIOLOGY AND TOXICOLOGY, 2023, 39 (02) : 537 - 556
  • [3] The role of tumor microenvironment and exosomes in dormancy and relapse
    Attaran, Shireen
    Bissell, Mina J.
    [J]. SEMINARS IN CANCER BIOLOGY, 2022, 78 : 35 - 44
  • [4] Emerging role of tumor microenvironment derived exosomes in therapeutic resistance and metastasis through epithelial-to-mesenchymal transition
    Balaji, Sekaran
    Kim, Usha
    Muthukkaruppan, Veerappan
    Vanniarajan, Ayyasamy
    [J]. LIFE SCIENCES, 2021, 280
  • [5] Glioma: molecular signature and crossroads with tumor microenvironment
    Barthel, Lennart
    Hadamitzky, Martin
    Dammann, Philipp
    Schedlowski, Manfred
    Sure, Ulrich
    Thakur, Basant Kumar
    Hetze, Susann
    [J]. CANCER AND METASTASIS REVIEWS, 2022, 41 (01) : 53 - 75
  • [6] Bone-a-Petite: Engineering Exosomes towards Bone, Osteochondral, and Cartilage Repair
    Bei, Ho Pan
    Hung, Pak Ming
    Yeung, Hau Lam
    Wang, Shuqi
    Zhao, Xin
    [J]. SMALL, 2021, 17 (50)
  • [7] Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies
    Bhattacharjee, Rahul
    Das, Sabya Sachi
    Biswal, Smruti Sudha
    Nath, Arijit
    Das, Debangshi
    Basu, Asmita
    Malik, Sumira
    Kumar, Lamha
    Kar, Sulagna
    Singh, Sandeep Kumar
    Upadhye, Vijay Jagdish
    Iqbal, Danish
    Almojam, Suliman
    Roychoudhury, Shubhadeep
    Ojha, Shreesh
    Ruokolainen, Janne
    Jha, Niraj Kumar
    Kesari, Kavindra Kumar
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 174
  • [8] Cao S, 2022, CELL BIOL TOXICOL
  • [9] Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance
    Capula, Mjriam
    Peran, Macarena
    Xu, Geng
    Donati, Valentina
    Yee, Dicky
    Gregori, Alessandro
    Assaraf, Yehuda G.
    Giovannetti, Elisa
    Deng, Dongmei
    [J]. DRUG RESISTANCE UPDATES, 2022, 64
  • [10] Targeting ALK in neuroblastoma-preclinical and clinical advancements
    Carpenter, Erica L.
    Mosse, Yael P.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (07) : 391 - 399